Literature DB >> 3446824

Acute exposure to rhodamine B.

D J Dire1, J A Wilkinson.   

Abstract

Rhodamine B is a red colored dye that is used in cosmetic products. We report a case of 17 patients who were exposed to aerosolized Rhodamine B inside a maintenance shop. The mean duration of exposure was 26 minutes (range 2-65). Sixteen of the patients (94%) complained of acute symptoms including: burning of the eyes (82%), excessive tearing (47%), nasal burning (41%), nasal itching (35%), chest pain/tightness (35%), rhinorhea (29%), cough (29%), dyspnea (29%), burning of the throat (24%), burning/pruritic skin (24%), chest burning (12%), headache (6%), and nausea (6%). All of the patients had resolution of their symptoms within 24 hours (less than 4 hours in 63%). Acute exposure to Rhodamine B resulted in transient mucous membrane and skin irritation without evidence of serious sequellae.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3446824     DOI: 10.3109/15563658708992660

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  4 in total

1.  Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II.

Authors:  A Friso; R Tomanin; M Salvalaio; M Scarpa
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

2.  In vitro activity of fluorescent dyes against asexual blood stages of Plasmodium falciparum.

Authors:  Fanny Joanny; Jana Held; Benjamin Mordmüller
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

Review 3.  Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.

Authors:  Maria Francisca Coutinho; Juliana Inês Santos; Sandra Alves
Journal:  Int J Mol Sci       Date:  2016-07-04       Impact factor: 5.923

4.  Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice.

Authors:  Ainslie L K Derrick-Roberts; Matilda R Jackson; Carmen E Pyragius; Sharon Byers
Journal:  Diseases       Date:  2017-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.